Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -77.83%107.68K | -97.22%13.7K | -53.65%224.9K | 17.35%1.84M | -71.55%380.75K | 1,140.06%485.66K | 349.46%492.75K | 1,383.01%485.18K | 138.19%1.57M | 195.61%1.34M |
| Operating revenue | --0 | -97.20%13.5K | -53.24%221.35K | 23.30%1.8M | -59.31%509.22K | 1,872.45%475.66K | 1,374.86%482.52K | 1,347.07%473.43K | 905.42%1.46M | 22,396.51%1.25M |
| Cost of revenue | -100K | 0 | ||||||||
| Gross profit | -77.83%107.68K | 485.66K | ||||||||
| Operating expense | -86.31%487.34K | -81.28%782.8K | -43.97%1.72M | -31.36%14.23M | -78.58%3.42M | 117.08%3.56M | -52.21%4.18M | -64.98%3.06M | 89.86%20.73M | 435.54%15.98M |
| Selling and administrative expenses | -88.96%354.12K | -83.60%561.84K | -48.39%1.21M | -36.87%11.17M | -84.84%2.15M | 167.86%3.21M | -57.98%3.43M | -71.14%2.35M | 93.15%17.7M | 401.47%14.21M |
| -Selling and marketing expense | -99.18%4.93K | --0 | -90.35%41.9K | 13.84%2.08M | --319.02K | --598.48K | 74.33%716.32K | 5.64%434.08K | 215.50%1.83M | ---- |
| -General and administrative expense | -86.62%349.18K | -79.26%561.84K | -38.89%1.17M | -42.71%9.09M | -85.18%1.84M | 117.88%2.61M | -65.00%2.71M | -75.22%1.92M | 84.90%15.87M | 353.00%12.38M |
| Research and development costs | -59.57%109.26K | -42.66%190.74K | -29.81%215.24K | 7.86%1.28M | -68.21%374.55K | 23,298.70%270.26K | 161.83%332.65K | 148.38%306.63K | 64.37%1.19M | 279.81%1.18M |
| Depreciation amortization depletion | -70.39%23.96K | -93.99%23.84K | -29.56%280.27K | -0.74%1.67M | 53.22%793.39K | -79.55%80.94K | -10.38%396.63K | -10.09%397.92K | 76.91%1.68M | 317.75%517.8K |
| -Depreciation and amortization | -70.39%23.96K | -93.99%23.84K | -29.56%280.27K | -0.74%1.67M | 53.22%793.39K | -79.55%80.94K | -10.38%396.63K | -10.09%397.92K | 76.91%1.68M | 317.75%517.8K |
| Other operating expenses | 3,475.81%204K | -77.01%6.38K | 2.77%6.98K | -35.62%100.86K | 13.72%86.07K | -87.33%5.71K | -9.68%27.77K | -77.92%6.79K | 97.84%156.66K | -3.11%75.69K |
| Operating profit | 87.65%-379.66K | 79.15%-769.1K | 42.15%-1.49M | 35.35%-12.38M | 79.22%-3.04M | -92.04%-3.07M | 57.31%-3.69M | 70.42%-2.58M | -86.75%-19.16M | -478.45%-14.64M |
| Net non-operating interest income (expenses) | 86.16%-66.24K | 45.06%-128.7K | -316.82%-158.84K | -21.94%-540.64K | 150.42%208.63K | -5,181.94%-478.65K | -2,002.15%-234.26K | -111.93%-38.11K | -438.28%-443.38K | -951.86%-413.79K |
| Non-operating interest expense | -86.16%66.24K | -45.06%128.7K | 316.82%158.84K | 21.94%540.64K | -150.42%-208.63K | 5,181.94%478.65K | 2,002.15%234.26K | 111.93%38.11K | 438.28%443.38K | 951.86%413.79K |
| Other net income (expenses) | -73.37%-791.72K | -114.22%-261.82K | 3,597.04%9.83M | 87.49%-1.08M | 97.62%-214.65K | -1,005.16%-456.68K | -526.16%-122.22K | -366.08%-280.96K | -968.88%-8.6M | -2,032.39%-9.03M |
| Gain on sale of security | 48.32%-246.62K | 726.62%163.8K | 6,736.56%1.38M | 25.24%-24.85K | 2,773.86%856.3K | -662,683.33%-477.2K | 253.54%19.82K | -24.95%-20.79K | -172.86%-33.23K | -228,850.00%-32.03K |
| Special income (charges) | -642.91%-111.45K | --99.84K | --9.38M | 92.84%-613.42K | 92.95%-633.95K | 149.76%20.53K | --0 | --0 | -981.12%-8.56M | ---9M |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --7.52M | ---- |
| -Less:Other special charges | 642.91%111.45K | ---99.84K | ---81.08K | ---163.09K | ---142.56K | ---20.53K | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | 163.28%558.74K | ---- | ---- | ---- | ---- | --212.22K | ---- |
| -Gain on sale of business | --0 | --0 | --9.3M | 73.69%-217.76K | 82.73%-217.76K | --0 | --0 | --0 | -4.49%-827.61K | ---1.26M |
| Other non-operating income (expenses) | ---- | ---1.05K | ---228.09K | ---437K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 69.12%-1.24M | 71.34%-1.16M | 382.28%8.18M | 50.35%-14M | 87.34%-3.05M | -142.85%-4.01M | 53.08%-4.05M | 66.42%-2.9M | -153.01%-28.2M | -704.41%-24.08M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 69.12%-1.24M | 71.34%-1.16M | 382.28%8.18M | 50.35%-14M | 87.34%-3.05M | -142.85%-4.01M | 53.08%-4.05M | 66.42%-2.9M | -153.01%-28.2M | -704.41%-24.08M |
| Net income continuous operations | 69.12%-1.24M | 71.34%-1.16M | 382.28%8.18M | 50.35%-14M | 87.34%-3.05M | -142.85%-4.01M | 53.08%-4.05M | 66.42%-2.9M | -153.01%-28.2M | -704.41%-24.08M |
| Noncontrolling interests | 0 | 79.29%-377.97K | 67.34%-377.97K | 51.21%-4.21M | 1.17M | -1.97M | -1.82M | -1.16M | -8.62M | |
| Net income attributable to the company | 39.37%-1.24M | 64.81%-781.66K | 591.87%8.55M | 49.97%-9.79M | 72.73%-4.21M | -23.66%-2.04M | 74.24%-2.22M | 79.84%-1.74M | -75.62%-19.57M | -416.34%-15.46M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 39.37%-1.24M | 64.81%-781.66K | 591.87%8.55M | 49.97%-9.79M | 72.73%-4.21M | -23.66%-2.04M | 74.24%-2.22M | 79.84%-1.74M | -75.62%-19.57M | -416.34%-15.46M |
| Diluted earnings per share | 0 | 0 | 400.00%0.3 | 50.00%-0.4 | 68.36%-0.2 | -54.08%-0.1 | 75.00%-0.1 | 75.00%-0.1 | -60.00%-0.8 | -296.89%-0.6322 |
| Basic earnings per share | 0 | 0 | 400.00%0.3 | 50.00%-0.4 | 68.36%-0.2 | -54.08%-0.1 | 75.00%-0.1 | 75.00%-0.1 | -60.00%-0.8 | -296.89%-0.6322 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.